MAX Chat
Dechra Pharmaceuticals PLC
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
2/10
|
53.05 | 41.32 | 28.38% | 60.82 | -12.78% |
| P/S |
|
5.51 | 14.79 | -62.76% |
|
|
| P/BV |
|
5.55 | 8.86 | -37.28% |
|
|
| P/FCF |
|
0 | 42.51 | -100% |
|
|
| Ev/Ebitda |
|
47.14 | 117.37 | -59.83% |
|
|
| Ev/S |
|
6.07 | 13.56 | -55.2% |
|
|
| Ev/FCF |
|
138.88 | 34.61 | 301.32% |
|
|
| E/P |
|
0 | 0.8104 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
12.88 | 10.68 | 20.66% | 23 | -44% |
| ROE |
|
-3.69 | 15.59 | -123.7% |
|
|
| ROA |
|
-1.78 | 8.77 | -120.28% |
|
|
| ROIC |
|
0 | 46.45 | -100% |
|
|
| ROS |
|
-3.66 | 19.49 | -118.78% |
|
|
| ROCE |
|
1.11 | 5.71 | -80.55% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.01 | 0.0036 | 137380.81% | 3.67 | +36.53% |
| Nеt Debt/Ebitda |
|
4.38 | -0.1028 | -4366.14% |
|
|
| Debt/Ratio |
|
0.3132 | 0.1549 | 102.24% |
|
|
| Debt/Equity |
|
1.08 | 2.78 | -61.2% |
|
|
| Debt/Net Income |
|
-17.62 | 5.46 | -422.43% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 7.14 | -100% | 1.25 | -100% |
| Number of years of dividend growth |
|
2 | 3 | -33.33% | ||
| DSI |
|
0.7857 | 0.9306 | -15.57% |
|
|
| Average dividend growth |
|
23.77 | 31.67 | -24.96% |
|
|
| Average percentage for 5 years |
|
1.25 | 6.65 | -81.21% |
|
|
| Average percentage for payments |
|
60.21 | 75.82 | -20.58% |
|
|
| Difference from average difference in sector |
|
-7.14 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
7/10
|
58.05 | -28.42 | -304.26% | ||
| Growth impulse Ebitda in 5 years |
|
-19.98 | 123.36 | -116.2% | ||
| Growth impulse Net Income in 5 years |
|
-190.29 | -81.81 | 132.6% | ||
| Growth impulse FCF in 5 years |
|
-43.84 | -59.78 | -26.66% | ||
| Growth impulse EPS in 5 years |
|
-233.04 | 4120.94 | -105.66% |
IP Score
3.14/10
